2024 Gingko bioworks stock - A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

 
The End of the Beginning: Ginkgo Goes Public. Last Friday, the Ginkgo team and their families rang the opening bell at the New York Stock Exchange announcing our debut as a publicly traded company under the NYSE ticker DNA, after raising $1.6 billion to accelerate our mission to make biology easier to engineer.. Gingko bioworks stock

Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ...Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a …11 de mai. de 2021 ... ... stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with ...The firm is now DNA stock's largest shareholder. Ginkgo Bioworks (NYSE: DNA) is in the red today, despite a recent transaction with $182 billion investment firm Baillie Gifford. Based on an ...18 de ago. de 2023 ... Summary · Ginkgo Bioworks' second quarter results were poor, with soft results in both the Cell Engineering and Biosecurity businesses. · The ...8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Feb 24, 2023 · Ginkgo Bioworks (DNA-7.19%) is a biotech that's operating on multiple bleeding edges of innovation as it works to engineer and manufacture biological cells at scale. Between its highly automated ... 6 de mar. de 2023 ... The Price is Finally Right. As we mentioned earlier, Ginkgo Bioworks stock is finally trading at a simple valuation ratio (market cap/annualized ...6 de mar. de 2023 ... The Price is Finally Right. As we mentioned earlier, Ginkgo Bioworks stock is finally trading at a simple valuation ratio (market cap/annualized ...With shares of Ginkgo Bioworks (DNA-7.19%) collapsing by 63% in the last 12 months, you'd be forgiven if you thought the biotech's heyday had ended.. But for daring investors who can tolerate ...The company has gotten a lot of attention from Wall Street, but the jury is out on whether Ginkgo can pull off its vision. One of the most bullish investors in Ginkgo Bioworks is Cathie Wood, the ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours Volume: 270.43K Advanced...Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours …Aug 16, 2022 · Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to ... 16 de nov. de 2022 ... Ginkgo has granted BTIG, the sole book-running manager for the offering, a 30-day option to purchase up to an additional $15 million shares ...Feb 22, 2023 · Ginkgo Bioworks delivers some encouraging results. In January, Ginkgo released preliminary numbers for the full-year 2022 that indicated strong growth. The company expects its total revenue to ... How Could You Make A Quick Recovery From Ginkgo Bioworks Holdings Inc (NYSE: DNA) Given A -400.0% Drop From Highs? Marketing Sentinel about 4 hours ago Facing Competition, But Still Strong: Ginkgo Bioworks Holdings Inc (NYSE:DNA) Is in red zone with the indicator reading -3.47% Stock Equity about 12 hours ago 3 Synthetic Biology …Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis.18 de ago. de 2023 ... Summary · Ginkgo Bioworks' second quarter results were poor, with soft results in both the Cell Engineering and Biosecurity businesses. · The ...Jul 25, 2022 · Two major developments, including a big acquisition, are moving DNA stock today. Ginkgo Bioworks ( DNA) has agreed to acquire Bayer’s ( BAYRY) research and development center. Furthermore ... Ginkgo Bioworks Company Info. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and ...Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. May 4, 2023 · Ginkgo Bioworks (DNA-3.47%) helps companies produce bio-engineered products that can be game changers in their respective industries. One example includes working with marijuana producer Cronos ... 4 de jan. de 2022 ... Ginkgo's Platform: A Foundry Tour (Ginkgo Bioworks Investor Day 2021) ... Why We're Avoiding Ginkgo Bioworks Stock $DNA. Nanalyze•12K views · 9 ...Ginkgo Bioworks Holdings, Inc. (DNA) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 1.4200 +0.1300 (+10.08%) As of 03:32PM EST. Market open. 1d 5d 1mNowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA) shareholders that were waiting for something to happen have been dealt a blow with a 30% share price drop in …Ginkgo Bioworks' platform consists of its Foundries and Codebase. Foundries are Ginkgo Bioworks way to automate organism design and Codebase is Ginkgo Bioworks' library of cell, enzyme and genetic …When shares of innovative growth stocks like Ginkgo Bioworks ( DNA -4.79%) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by ...Stock analysis for Ginkgo Bioworks Holdings Inc (9L4:Berlin) including stock price, stock chart, company news, key statistics, fundamentals and company ...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ...Sep 17, 2021 · Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. Shares opened at $11.15 apiece under ticker ... In 2022’s first quarter, Ginkgo Bioworks reported a net earnings loss that widened considerably. Shockingly, the company’s net loss deepened from $74.78 million in the first quarter of 2021 ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Shares of Ginkgo Bioworks ( DNA 5.80%) were jumping 18.2% higher as of 10:58 a.m. ET. The nice gain came after the company announced its 2021 fourth-quarter and full-year results. Ginkgo reported ...Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion.With its shares popping by more than 21% in a day in the aftermath of its latest earnings report, Ginkgo Bioworks ( DNA 4.11%) is a hot biotech company that's ripe for investment. After reporting ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.One of the most bullish investors in Ginkgo Bioworks is Cathie Wood, the CEO of Ark Invest. Just in October alone Wood has bought roughly 5 million shares in Ginkgo Bioworks across several of her ...Oct 13, 2021 · The honeymoon for newly minted Ginkgo Bioworks ( DNA 4.11%) shares recently came to an abrupt end, and it didn't take long. The synthetic-biology start-up just made its stock market debut in mid ... The main competitors of Ginkgo Bioworks include Krystal Biotech (KRYS), ImmunityBio (IBRX), Denali Therapeutics (DNLI), Arcellx (ACLX), Beam Therapeutics (BEAM), Revolution Medicines (RVMD), Immunocore (IMCR), Neumora Therapeutics (NMRA), Vericel (VCEL), and Recursion Pharmaceuticals (RXRX). These companies are …Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours Volume: 270.43K Advanced... Ginkgo Bioworks Holdings Inc (DNA) share price as of December 1, 2023, is $1.43. If you are investing from India, you can always check the valuation in the INR ...Ginkgo Bioworks Holdings Aktie Profil Die Ginkgo Bioworks Holdings Aktie wird unter der ISIN US37611X1000 an den Börsen Frankfurt, München, Berlin, New York, NYSE MKT, Bats, NYSE Bsc, Gettex ...27 Nov, 2023, 07:00 ET. Vivici has formed a partnership with Ginkgo to advance production of a sustainable and nutritious dairy protein, made via precision fermentation. Ginkgo will …8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations. Evgenii Kovalev. Ginkgo Bioworks (NYSE:DNA) is still finding its feet as a public company, with the stock continuing to decline on the back of valuation concerns and declining Biosecurity revenue ...Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions... Interactive Chart for Ginkgo Bioworks Holdings, Inc. (DNA), analyze all the data with a huge range of indicators.8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.The Ginkgo Bioworks stock price fell by -3.50% on the last day (Wednesday, 22nd Nov 2023) from $1.43 to $1.38. During the last trading day the stock fluctuated 8.82% from a day low at $1.36 to a day high of $1.48. The price has risen in 5 of the last 10 days but is still down by -7.38% for this period. Volume has increased on the last day by ...Wood keeps buying DNA stock despite it being down more than 60% so far this year. Cathie Wood has been adding shares of biotech company Ginkgo Bioworks ( DNA) to her exchange-traded funds (ETFs ...Select Year: Date Filing Type Filing Description Download. 11/28/2023. 144. Report of proposed sale of securities. 11/27/2023. 4. Statement of Changes in Beneficial Ownership. 11/27/2023.$478 million of total revenue in 2022, representing an increase of 52% over 2021 and toward the high end of guidance. 59 new Cell Programs added in 2022, representing 90% growth over 2021 and toward the high end of guidance. Year end cash balance of over $1.3 billion provides meaningful multi-year runway as we drive towards …Ginkgo Bioworks. 15 Nov, 2022, 16:17 ET. BOSTON, Nov. 15, 2022 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"),which is building the leading platform for cell programing and ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial …May 4, 2023 · Ginkgo Bioworks (DNA-3.47%) helps companies produce bio-engineered products that can be game changers in their respective industries. One example includes working with marijuana producer Cronos ... See Ginkgo Bioworks Holdings, Inc. (DNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results. $478 million of total revenue in 2022, representing an increase of 52% over …Next-generation biotech Ginkgo Bioworks Holdings ( DNA -3.50%) was one of the star stocks in its sector this week. According to data compiled by S&P Global Market Intelligence, the company's share ...Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shareholders that were waiting for something to happen have been dealt a blow with a 30% share price drop in the last month. The recent drop completes a ...Track Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A (DNA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to ...Ginkgo Bioworks Holdings, Inc. provides horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals.Ginkgo Bioworks Holdings, Inc. provides horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals.13 de jan. de 2023 ... As Ginkgo stock sinks, CEO Jason Kelly tries to win over drugmakers in San Francisco · Jason Mast · Matthew Herper.DNA - Ginkgo Bioworks Holdings Inc - Class A Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)Nov 27, 2023 · Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. Ginkgo Bioworks Holdings Aktie Profil Die Ginkgo Bioworks Holdings Aktie wird unter der ISIN US37611X1000 an den Börsen Frankfurt, München, Berlin, New York, NYSE MKT, Bats, NYSE Bsc, Gettex ...Track Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A (DNA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSep 17, 2021 · Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. Shares opened at $11.15 apiece under ticker ... Ways to buy and sell Ginkgo Bioworks shares pre-IPO. Invest in proven Healthcare private companies like Ginkgo Bioworks at ForgeGlobal.com.Ginkgo Bioworks (NYSE: DNA) stock is rising higher on Wednesday after the company won a contract from the Defense Advanced Research Projects Agency (DARPA). This contract is worth $18 million over ...Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended ...Ark Invest has purchased Ginkgo Bioworks (NYSE: DNA) six times this month. Shares of Ginkgo Bioworks (NYSE: DNA) have had a disastrous 2022, with the company losing over 65% of its market ...Phone Number +1 877 422 5362. Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals.14.93%. Trailing 12-Months. The Ginkgo Bioworks Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system …Ginkgo Bioworks. Cathie Wood's Ark Invest is quickly building a position in a SPAC that plans to merge with Ginkgo Bioworks. The Ark Disruptive Innovation and Genomic Revolution ETFs doubled its ...Key Insights. Significantly high institutional ownership implies Ginkgo Bioworks Holdings' stock price is sensitive to their trading actions. A total of 7 investors have a majority stake in the ...Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Gingko bioworks stock

Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal. The Boston-based company will merge with Soaring Eagle Acquisition Corp., a blank-check firm .... Gingko bioworks stock

gingko bioworks stock

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shareholders that were waiting for something to happen have been dealt a blow with a 30% share price drop in the last month. The recent drop completes a ...3 days ago. Track Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A (DNA) Stock Price, Quote, latest community messages, chart, news and other stock related …Ginkgo Bioworks Stock Price, News & Analysis (NYSE:DNA) $1.42 +0.14 (+10.89%) (As of 12/1/2023 ET) Compare Today's Range $1.28 $1.43 50-Day Range …If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Nov 6, 2023 · November 6, 2023 at 8:50 AM · 4 min read. We expect investors to focus on the sales performance of Ginkgo Bioworks Holdings, Inc. ’s DNA two business units when the company reports third ... Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts ...Find out the direct holders, institutional holders and mutual fund holders for Ginkgo Bioworks Holdings, Inc. (DNA).“Ginkgo Bioworks does not deserve to use the DNA ticker,” said Stat stock reporter Adam Feuerstein. SPACs are a Wall Street trend that offers an IPO path with a little less than the usual ...Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.Ginkgo Bioworks Holdings Inc (DNA) Sell: $1.45 Buy: $1.46 $0.08 (5.80%) Market closed | Prices as at close on 24 November 2023 | Turn on streaming prices. Add to watchlist. This stock can be held ...Bought 8.0 Million shares of Ginkgo Bioworks Holdings ... Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. ...Ginkgo Bioworks Holdings Inc - Class A (NYSE:DNA) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.Further stock offerings could send the company's share price into even more of a tailspin. The good news is that, for now, Ginkgo is well-funded. As of the end of 2022, its cash balance was around ...Short History of Ginkgo Bioworks Stock Coverage We first started writing about Ginkgo Bioworks back in March 2016 in an article about three nanorobot factories . Since then, we’ve written at least another half-dozen articles about the Boston-based company, which has basically turned lab R&D for designing and programming cells into a high ... Ginkgo Bioworks (NYSE: DNA) stock is in full focus today following ownership updates from three co-founders.The cell programming company has become a favorite of Ark Invest’s Cathie Wood. As of ...Stock Info Stock Quote Price $1.39 Volume 65 Change -0.07 % Change -4.79% Today's Open $1.44 Previous Close $1.46 Intraday High $1.46 Intraday Low $1.38 52 Week High …See Also: Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam' Besides Ark Invest, Microsoft Corp (NASDAQ:MSFT) cofounder Bill Gates is the other known high-profile ...Ginkgo Bioworks. Market Cap. $3B. Today's Change. (10.85%) $0.14. Current Price. $1.43. Price as of December 1, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ...Ginkgo Bioworks Price Performance. Shares of Ginkgo Bioworks stock opened at $1.29 on Friday. Ginkgo Bioworks Holdings, Inc. has a 1 year low of $1.12 and a 1 year high of $2.55. The business has a 50-day moving average of $1.55 and a two-hundred day moving average of $1.77.Here’s how four startups are programming biology to develop new products in medicine, energy, food and more. Get the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock …Ginkgo Bioworks' platform consists of its Foundries and Codebase. Foundries are Ginkgo Bioworks way to automate organism design and Codebase is Ginkgo Bioworks' library of cell, enzyme and genetic …In about an hour following the publication of Scorpion’s 175-page report, Ginkgo’s stock price dropped at least 20%, down to about $9.50 a share.8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results. $478 million of total revenue in 2022, representing an increase of 52% over 2021 and toward the high end of guidance ...The Ginkgo Bioworks stock price fell by -3.50% on the last day (Wednesday, 22nd Nov 2023) from $1.43 to $1.38. During the last trading day the stock fluctuated 8.82% from a day low at $1.36 to a day high of $1.48. The price has risen in 5 of the last 10 days but is still down by -7.38% for this period. Volume has increased on the last day by ...Next-generation biotech Ginkgo Bioworks Holdings ( DNA -3.50%) was one of the star stocks in its sector this week. According to data compiled by S&P Global Market Intelligence, the company's share ...See the company profile for Ginkgo Bioworks Holdings, Inc. (DNA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ... Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis. Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours Volume: 270.43K Advanced...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Ginkgo Bioworks Company Info. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and ...Ginkgo Bioworks Follow Share $0.12 Dec 1, 4:15:01 PM GMT-5 · USD · NYSE · Disclaimer search Compare to In the news The Motley Fool 30 minutes ago If You Invested $1,000 in Ginkgo Bioworks...Ginkgo Bioworks ( DNA -7.19%) is a biotech that's operating on multiple bleeding edges of innovation as it works to engineer and manufacture biological cells at scale. Between its highly automated ...Nov 29, 2023 · Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $112,837, According to a Recent SEC Filing. MT. Summary. Quotes. Charts. The average price point forecasted by analysts for Ginkgo Bioworks Holdings Inc (DNA) is $3.38, which is $1.92 above the current market price. The public float for DNA is 1.30B, and currently, short sellers hold a 18.11% ratio of that floaft. The average trading volume of DNA on November 27, 2023 was 19.63M shares. Top 5 EV Tech …Ginkgo Bioworks Follow Share $0.12 Dec 1, 4:15:01 PM GMT-5 · USD · NYSE · Disclaimer search Compare to In the news The Motley Fool 30 minutes ago If You Invested $1,000 …Symbols that represent hope include the gingko tree, the color blue and anchors. Much of this symbolism has Christian origins. Some of the symbols that represent hope include:The Ginkgo Bioworks stock price fell by -3.50% on the last day (Wednesday, 22nd Nov 2023) from $1.43 to $1.38. During the last trading day the stock fluctuated 8.82% from a day low at $1.36 to a day high of $1.48. The price has risen in 5 of the last 10 days but is still down by -7.38% for this period. Volume has increased on the …Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion.Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a …Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results. $478 million of total revenue in 2022, representing an increase of 52% over 2021 and toward the high end of guidance ...Further stock offerings could send the company's share price into even more of a tailspin. The good news is that, for now, Ginkgo is well-funded. As of the end of 2022, its cash balance was around ...Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis.10 stocks we like better than Ginkgo Bioworks. When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ...Cathie Wood's position in Ginkgo Bioworks Holdings is currently worth $261 Million. That's 1.69% of their equity portfolio (18th largest holding). The investor owns 11.38% of the outstanding Ginkgo Bioworks Holdings stock. The investor's estimated purchase price is $916 Million, resulting in a loss of 72%.Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to ...The latest Ginkgo Bioworks Holdings stock prices, stock quotes, news, and DNA history to help you invest and trade smarter.Get the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock news and headlines to help you in your trading and investing decisions.3.90. Nikko Asset Management Americas, Inc. 3.67. ARK Genomic Revolution ETF. 3.25. The latest Ginkgo Bioworks Holdings stock prices, stock quotes, news, and DNA history to help you invest and ...Stock analysis for Ginkgo Bioworks Holdings Inc (9L4:Berlin) including stock price, stock chart, company news, key statistics, fundamentals and company ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.10 stocks we like better than Ginkgo Bioworks. When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ...About Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food ...May 20, 2022 · Shares of Ginkgo Bioworks (NYSE: DNA) have had a disastrous 2022, with the company losing over 65% of its market capitalization so far. The biotech company focuses on utilizing genetic engineering ... Click here to read why DNA stock is a Buy. ... Cathie Wood Keeps Buying Ginkgo Bioworks (DNA) Stock. Reply Like. G. GrgeS. 11 Feb. 2023. Premium. Comments (7) @HadM62 that is the scariest part of ...DNA - Ginkgo Bioworks Holdings Inc - Class A Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)Get the latest Ginkgo Bioworks Holdings Inc (DNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Two major developments, including a big acquisition, are moving DNA stock today. Ginkgo Bioworks ( DNA) has agreed to acquire Bayer’s ( BAYRY) research and development center. Furthermore ...Ginkgo Bioworks. 15 Nov, 2022, 16:17 ET. BOSTON, Nov. 15, 2022 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"),which is building the leading platform for cell programing and ...Ginkgo Bioworks is still a story stock and one that's expensive to buy into. ... Gingko Bioworks operates a two-ended business model, where it charges an upfront fee to begin a program, and back .... Clm dividend history